Prajakta A. Sonalker, Ph.D.
A hallmark of Prajakta’s practice is her experience architecting cross-border litigation strategies. She coordinates actions across jurisdictions, working with international teams and managing parallel proceedings to align legal, scientific, and business objectives. Her experience includes complex, multi-jurisdictional matters requiring coordination of parties, evidence, and legal issues.
Prajakta has handled disputes at all stages, from pre-suit investigation through trial and appeal, including proceedings before the Patent Trial and Appeal Board (PTAB). She also advises clients on risk assessment, freedom-to-operate issues, and dispute strategy in connection with licensing, transactions, and product development.
Prajakta draws on nearly two decades of experience in private practice and in-house roles, bringing a practical, business-oriented perspective to complex disputes.
Related Practices
Related Industries
Experience
Representative Matters
- Served as lead counsel in a high-stakes dispute involving gene-editing technology with cross-border elements
- Represented a major biopharmaceutical company in complex patent and trade secret disputes involving a therapeutic vaccine
- Advised major pharmaceutical companies on dispute strategies and risk allocation in connection with licensing and collaboration agreements
- Represented an innovator biopharmaceutical company in its multi-billion-dollar acquisition of a cancer immunotherapy biotechnology company
- Represented a multinational pharmaceutical company in Hatch-Waxman litigation against multiple defendants concerning patents on an overactive bladder treatment
- Represented an innovator biopharmaceutical company in district court and PTAB proceedings concerning patents related to RNA interference technology
- Represented a multinational consumer goods company in Hatch-Waxman litigation against multiple defendants concerning patents related to long-acting cough medications
- Represented a multinational pharmaceutical company in Hatch-Waxman litigations concerning a patent on antifungal formulations
- Represented an innovator biopharmaceutical company in an interference proceeding involving nucleoside analogs useful for treating HCV infection
Representative Clients
- Alnylam
- Astellas Pharma
- Gilead
- Kite Pharma
- Reckitt Benckiser
Insights
Credentials
Education
- J.D. Fordham University School of Law 2013
- Ph.D. Molecular Pharmacology University of Pittsburgh 2006
- B.S. Pharmaceutical Sciences Institute of Chemical Technology, Mumbai, India 2001
Bar Admissions
- New Jersey
- New York
- U.S. Patent and Trademark Office
Court Admissions
- U.S. Court of Appeals for the Federal Circuit
- U.S. District Court for the District of New Jersey
Professional Memberships and Activities
- Fellow, Leadership Council on Legal Diversity (LCLD), 2023
- Member, New York Intellectual Property Law Association
- Member, New Jersey Intellectual Property Law Association
- Member, Intellectual Property Owners Association
Recognition
- The Best Lawyers in America, Ones to Watch, 2024 – 2025
- LMG Life Sciences, Rising Star, 2020